Forecasting the rise of middle meningeal artery embolization for chronic subdural hematoma patients: United States projections from 2022 to 2050
The projected increase in cSDH and the corresponding rise in MMAE-eligible patients signify a substantial emerging public health challenge. Anticipating a 13.5% growth in incidence by 2050, these findings emphasize the urgent need for proactive healthcare planning and resource allocation to accommodate the escalating demand for specialized interventions like MMAE.
Authors
- Joshua S. Catapano (ORCID: https://orcid.org/0000-0001-6599-0269)
- Rashad Jabarkheel (ORCID: https://orcid.org/0000-0002-7643-2622)
- Oleg Shekhtman (ORCID: https://orcid.org/0000-0002-7871-9539)
- Avi A. Gajjar
- Ilayda Kayir
- Mohamed M Salem
- Alexander D M Gerlach
- Jan-Karl Burkhardt
- Visish M Srinivasan
Institutions
- Bahçeşehir University (TR)
- Hospital of the University of Pennsylvania (US)
- University of Pennsylvania Health System (US)
- University of Colorado Anschutz Medical Campus (US)
- Albany Medical Center Hospital (US)
Publication Details
- Journal
- Journal of neurosurgery
- Published
- 2026-02-01
- DOI
- https://doi.org/10.3171/2025.9.jns25749
- Primary Topic
- Neurosurgical Procedures and Complications
- Type
- article
- Field-Weighted Citation Impact
- 0.00